About CAP-TB

Control and Prevention of Tuberculosis (CAP-TB) is a five-year project funded by the U.S. Agency for International Development (USAID) to reduce the incidence and mortality from Multi-Drug Resistant TB (MDR-TB.)  The project’s overall aim is to develop a model for cost-effective MDR-TB control that can be sustainably expanded throughout Myanmar, China, and Thailand. The prime cooperating agency for the CAP-TB Project is FHI 360, with teams of professionals in each of the countries.

The CAP-TB strategy is to provide patient-centered, community-driven support for MDR-TB elimination.  Led by FHI 360, the prime cooperating agency, and its implementing agencies, the CAP-TB team carries out this strategy to meet the following objectives:

  • To prevent disease transmission through effective infection control.  This is a critical element for MDR-TB control and prevention, particularly in settings where treatment is delayed due to shortage of second-line drugs or laboratory confirmation of molecular diagnosis is slow.
  • To increase early MDR-TB diagnosis through effective identification of people at risk and referring them into the TB system.  Training physicians, health care workers, and community workers on early referral for faster identification of presumptive TB patients; and educating at-risk populations about TB/MDR-TB signs and symptoms are critical for early diagnosis.
  • To maximize treatment success through provision of a comprehensive “living support package” over 24 months of MDR-TB treatment.  The package includes nutrition and transportation support; psychosocial care through patient support groups and TB/MDR-TB peer counsellors; and conducting home visits, phone calls, and social media connections for TB patients.  Specific components of the package are customized to each country, depending on the local needs.

 The CAP-TB strategic model is based on the foundational building blocks for TB and MDR-TB control:

The CAP-TB Project partners with the local organizations in Myanmar, China, and Thailand. See this site's Partners section to learn about the CAP-TB partners.


Home  |  Partners  |  Team  |  How to follow CAP-TB  |  What is on this site?  Contact us